EGFR and lung cancer: This dataset was a lung cancer cohort, containing normal individuals, those with epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) mutations, RAS mutations and wild type lung adenocarcinoma at different stages.